PRODUCT MONOGRAPH IMITREX DF IMITREX ... - GlaxoSmithKline

IMPORTANT: PLEASE READSERIOUS SIDE EFFECTS, HOW OFTEN THEYHAPPEN AND WHAT TO DO ABOUT THEMSymptom / effectTalk with yourdoctor orpharmacistOnlyifsevereIn allcasesSeekimmediatemedicalemergencyassistanceVery rare Loss of vision. This is not a complete list of side effects. For anyunexpected effects while taking IMITREX ® Injection,contact your doctor or pharmacist.HOW TO STORE ITKeep your medicine in a safe place where childrencannot reach it. It may be harmful to children.Keep your syringes away from heat and light whichmay spoil them. Always keep your injection in the caseprovided and store between 2°C and 30°C.If your medication has expired (the expiration date isprinted on the treatment pack), throw it away asinstructed. Needles and syringes may be hazardous andshould be disposed of safely and hygienically. Do notthrow away your IMITREX STATdose Pen ®autoinjector.If your doctor decides to stop your treatment, do notkeep any leftover medicine unless your doctor tells youto. Throw away your medicine as instructed.Reminder:REMEMBER: This medicine is for you. Only a doctorcan prescribe it for you. Never give it to someone else.It may harm them even if their symptoms appear to besimilar to yours.REPORTING SUSPECTED SIDE EFFECTSYou can report any suspected adverse reactionsassociated with the use of health products to the CanadaVigilance Program by one of the following 3 ways:• Report online at www.healthcanada.gc.ca/medeffect• Call toll-free at 1-866-234-2345• Complete a Canada Vigilance Reporting Form and:- Fax toll-free to 1-866-678-6789, or- Mail to: Canada Vigilance ProgramHealth CanadaPostal Locator 0701COttawa, ON K1A 0K9Postage paid labels, Canada Vigilance Reporting Formand the adverse reaction reporting guidelines areavailable on the MedEffect Canada Web site atwww.healthcanada.gc.ca/medeffect.NOTE: Should you require information related to themanagement of side effects, contact your healthprofessional. The Canada Vigilance Program does notprovide medical advice.MORE INFORMATIONThis document plus the full product monograph, prepared forhealth professionals can be found at:http://www.gsk.ca or by contacting the sponsor,GlaxoSmithKline Inc.7333 Mississauga RoadMississauga, OntarioL5N 6L41-800-387-7374This leaflet was prepared by GlaxoSmithKline Inc.Last revised: October 21, 2014© 2014 GlaxoSmithKline, All Rights Reserved® IMITREX, ® IMITREX STATdose Pen and IMITREX STATdoseSystem are registered trademarks, used under license byGlaxoSmithKline Inc.October 21, 2014Page 53 of 58